Type B lactic acidosis, an uncommon paraneoplastic syndrome
A 67-year-old male presented with anasarca and persistent non-pruritic rash of lower extremities. Physical examination was positive for subcutaneous edema with a non-blanching rash of abdomen and lower extremities. Labs showed leukocytosis, lymphocytosis, anemia and thrombocytopenia. He also had acu...
Gespeichert in:
Veröffentlicht in: | Cancer biology & therapy 2018-02, Vol.19 (2), p.101-104 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 104 |
---|---|
container_issue | 2 |
container_start_page | 101 |
container_title | Cancer biology & therapy |
container_volume | 19 |
creator | Wahab, Ahsan Kesari, Kavitha J Smith, Susan Liu, Yang Barta, Stefan K |
description | A 67-year-old male presented with anasarca and persistent non-pruritic rash of lower extremities. Physical examination was positive for subcutaneous edema with a non-blanching rash of abdomen and lower extremities. Labs showed leukocytosis, lymphocytosis, anemia and thrombocytopenia. He also had acute kidney injury and high anion gap (AG) metabolic acidosis with elevated lactic acid (11.3 mg/dL). Computerized tomography (CT) of abdomen and pelvis showed hepatosplenomegaly, ascites and abdominal lymphadenopathy. Peripheral blood (PB) smear showed blastiod appearing lymphocytes. He was started on bicarbonate infusion due to persistent lactic acidosis (LA), however showed no significant improvement. He was started on IV dexamethasone on 3rd day of hospitalization based on preliminary result of peripheral picture which led to some improvement in LA. Following the confirmation of mantle cell lymphoma (MCL) on bone marrow (BM) biopsy and immunophenotyping, the patient started receiving VR-CAP regimen (bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone) which led to significant improvement in LA and leukocytosis. After discharge, he received further chemotherapy with resolution of the LA and normalization of blood counts. Restaging tests confirmed a complete remission with resolution of the skin rash, resolution of the pathological lymphadenopathy and hepatosplenomegaly on imaging, and absence of lymphoma on a repeat BM biopsy. |
doi_str_mv | 10.1080/15384047.2017.1394550 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5790396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1984199609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-db6d5558cdb5afe5ccaf39b0b2ef20c30a57576246eccd0fe72af8650b7992533</originalsourceid><addsrcrecordid>eNpVkFtLxDAQhYMo7rr6E5Q--mDXSdI0DYKwLt5gwZf1OaRpopW2qUkr7L-3ZS_o0wzMmTNnPoQuMcwxZHCLGc0SSPicAOZzTEXCGByhKWaMxRnj6fHY0yweRRN0FsIXAOEkFadoQgQRNAGYorv1pjXRQ1Qp3ZU6UrosXCjDTaSaqG-0q2vXRK3yqjGurVQYRWHTFN7V5hydWFUFc7GrM_T-9LhevsSrt-fX5WIV6wTjLi7ytBhCZbrImbKGaa0sFTnkxFgCmoJifMhLktRoXYA1nCibpQxyLgRhlM7Q_da37fPaFNo0nVeVbH1ZK7-RTpXy_6QpP-WH-5GMC6AiHQyudwbeffcmdLIugzZVNX7VB4lFlmAhUhCDlG2l2rsQvLGHMxjkCF7uwcsRvNyBH_au_mY8bO1J019Eqn-I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1984199609</pqid></control><display><type>article</type><title>Type B lactic acidosis, an uncommon paraneoplastic syndrome</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wahab, Ahsan ; Kesari, Kavitha ; J Smith, Susan ; Liu, Yang ; Barta, Stefan K</creator><creatorcontrib>Wahab, Ahsan ; Kesari, Kavitha ; J Smith, Susan ; Liu, Yang ; Barta, Stefan K</creatorcontrib><description>A 67-year-old male presented with anasarca and persistent non-pruritic rash of lower extremities. Physical examination was positive for subcutaneous edema with a non-blanching rash of abdomen and lower extremities. Labs showed leukocytosis, lymphocytosis, anemia and thrombocytopenia. He also had acute kidney injury and high anion gap (AG) metabolic acidosis with elevated lactic acid (11.3 mg/dL). Computerized tomography (CT) of abdomen and pelvis showed hepatosplenomegaly, ascites and abdominal lymphadenopathy. Peripheral blood (PB) smear showed blastiod appearing lymphocytes. He was started on bicarbonate infusion due to persistent lactic acidosis (LA), however showed no significant improvement. He was started on IV dexamethasone on 3rd day of hospitalization based on preliminary result of peripheral picture which led to some improvement in LA. Following the confirmation of mantle cell lymphoma (MCL) on bone marrow (BM) biopsy and immunophenotyping, the patient started receiving VR-CAP regimen (bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone) which led to significant improvement in LA and leukocytosis. After discharge, he received further chemotherapy with resolution of the LA and normalization of blood counts. Restaging tests confirmed a complete remission with resolution of the skin rash, resolution of the pathological lymphadenopathy and hepatosplenomegaly on imaging, and absence of lymphoma on a repeat BM biopsy.</description><identifier>ISSN: 1538-4047</identifier><identifier>EISSN: 1555-8576</identifier><identifier>DOI: 10.1080/15384047.2017.1394550</identifier><identifier>PMID: 29293400</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Acidosis, Lactic - blood ; Acidosis, Lactic - drug therapy ; Acidosis, Lactic - etiology ; Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bedside to Bench Report ; Biopsy ; Bone Marrow - pathology ; Humans ; Lactic Acid - blood ; Lymphoma, Mantle-Cell - blood ; Lymphoma, Mantle-Cell - complications ; Lymphoma, Mantle-Cell - drug therapy ; Lymphoma, Mantle-Cell - pathology ; Male ; Paraneoplastic Syndromes - blood ; Paraneoplastic Syndromes - drug therapy ; Paraneoplastic Syndromes - etiology ; Treatment Outcome</subject><ispartof>Cancer biology & therapy, 2018-02, Vol.19 (2), p.101-104</ispartof><rights>2018 Taylor & Francis Group, LLC 2018 Taylor & Francis Group, LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-db6d5558cdb5afe5ccaf39b0b2ef20c30a57576246eccd0fe72af8650b7992533</citedby><cites>FETCH-LOGICAL-c411t-db6d5558cdb5afe5ccaf39b0b2ef20c30a57576246eccd0fe72af8650b7992533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790396/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790396/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29293400$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wahab, Ahsan</creatorcontrib><creatorcontrib>Kesari, Kavitha</creatorcontrib><creatorcontrib>J Smith, Susan</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Barta, Stefan K</creatorcontrib><title>Type B lactic acidosis, an uncommon paraneoplastic syndrome</title><title>Cancer biology & therapy</title><addtitle>Cancer Biol Ther</addtitle><description>A 67-year-old male presented with anasarca and persistent non-pruritic rash of lower extremities. Physical examination was positive for subcutaneous edema with a non-blanching rash of abdomen and lower extremities. Labs showed leukocytosis, lymphocytosis, anemia and thrombocytopenia. He also had acute kidney injury and high anion gap (AG) metabolic acidosis with elevated lactic acid (11.3 mg/dL). Computerized tomography (CT) of abdomen and pelvis showed hepatosplenomegaly, ascites and abdominal lymphadenopathy. Peripheral blood (PB) smear showed blastiod appearing lymphocytes. He was started on bicarbonate infusion due to persistent lactic acidosis (LA), however showed no significant improvement. He was started on IV dexamethasone on 3rd day of hospitalization based on preliminary result of peripheral picture which led to some improvement in LA. Following the confirmation of mantle cell lymphoma (MCL) on bone marrow (BM) biopsy and immunophenotyping, the patient started receiving VR-CAP regimen (bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone) which led to significant improvement in LA and leukocytosis. After discharge, he received further chemotherapy with resolution of the LA and normalization of blood counts. Restaging tests confirmed a complete remission with resolution of the skin rash, resolution of the pathological lymphadenopathy and hepatosplenomegaly on imaging, and absence of lymphoma on a repeat BM biopsy.</description><subject>Acidosis, Lactic - blood</subject><subject>Acidosis, Lactic - drug therapy</subject><subject>Acidosis, Lactic - etiology</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bedside to Bench Report</subject><subject>Biopsy</subject><subject>Bone Marrow - pathology</subject><subject>Humans</subject><subject>Lactic Acid - blood</subject><subject>Lymphoma, Mantle-Cell - blood</subject><subject>Lymphoma, Mantle-Cell - complications</subject><subject>Lymphoma, Mantle-Cell - drug therapy</subject><subject>Lymphoma, Mantle-Cell - pathology</subject><subject>Male</subject><subject>Paraneoplastic Syndromes - blood</subject><subject>Paraneoplastic Syndromes - drug therapy</subject><subject>Paraneoplastic Syndromes - etiology</subject><subject>Treatment Outcome</subject><issn>1538-4047</issn><issn>1555-8576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkFtLxDAQhYMo7rr6E5Q--mDXSdI0DYKwLt5gwZf1OaRpopW2qUkr7L-3ZS_o0wzMmTNnPoQuMcwxZHCLGc0SSPicAOZzTEXCGByhKWaMxRnj6fHY0yweRRN0FsIXAOEkFadoQgQRNAGYorv1pjXRQ1Qp3ZU6UrosXCjDTaSaqG-0q2vXRK3yqjGurVQYRWHTFN7V5hydWFUFc7GrM_T-9LhevsSrt-fX5WIV6wTjLi7ytBhCZbrImbKGaa0sFTnkxFgCmoJifMhLktRoXYA1nCibpQxyLgRhlM7Q_da37fPaFNo0nVeVbH1ZK7-RTpXy_6QpP-WH-5GMC6AiHQyudwbeffcmdLIugzZVNX7VB4lFlmAhUhCDlG2l2rsQvLGHMxjkCF7uwcsRvNyBH_au_mY8bO1J019Eqn-I</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Wahab, Ahsan</creator><creator>Kesari, Kavitha</creator><creator>J Smith, Susan</creator><creator>Liu, Yang</creator><creator>Barta, Stefan K</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180201</creationdate><title>Type B lactic acidosis, an uncommon paraneoplastic syndrome</title><author>Wahab, Ahsan ; Kesari, Kavitha ; J Smith, Susan ; Liu, Yang ; Barta, Stefan K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-db6d5558cdb5afe5ccaf39b0b2ef20c30a57576246eccd0fe72af8650b7992533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acidosis, Lactic - blood</topic><topic>Acidosis, Lactic - drug therapy</topic><topic>Acidosis, Lactic - etiology</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bedside to Bench Report</topic><topic>Biopsy</topic><topic>Bone Marrow - pathology</topic><topic>Humans</topic><topic>Lactic Acid - blood</topic><topic>Lymphoma, Mantle-Cell - blood</topic><topic>Lymphoma, Mantle-Cell - complications</topic><topic>Lymphoma, Mantle-Cell - drug therapy</topic><topic>Lymphoma, Mantle-Cell - pathology</topic><topic>Male</topic><topic>Paraneoplastic Syndromes - blood</topic><topic>Paraneoplastic Syndromes - drug therapy</topic><topic>Paraneoplastic Syndromes - etiology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wahab, Ahsan</creatorcontrib><creatorcontrib>Kesari, Kavitha</creatorcontrib><creatorcontrib>J Smith, Susan</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Barta, Stefan K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer biology & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wahab, Ahsan</au><au>Kesari, Kavitha</au><au>J Smith, Susan</au><au>Liu, Yang</au><au>Barta, Stefan K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type B lactic acidosis, an uncommon paraneoplastic syndrome</atitle><jtitle>Cancer biology & therapy</jtitle><addtitle>Cancer Biol Ther</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>19</volume><issue>2</issue><spage>101</spage><epage>104</epage><pages>101-104</pages><issn>1538-4047</issn><eissn>1555-8576</eissn><abstract>A 67-year-old male presented with anasarca and persistent non-pruritic rash of lower extremities. Physical examination was positive for subcutaneous edema with a non-blanching rash of abdomen and lower extremities. Labs showed leukocytosis, lymphocytosis, anemia and thrombocytopenia. He also had acute kidney injury and high anion gap (AG) metabolic acidosis with elevated lactic acid (11.3 mg/dL). Computerized tomography (CT) of abdomen and pelvis showed hepatosplenomegaly, ascites and abdominal lymphadenopathy. Peripheral blood (PB) smear showed blastiod appearing lymphocytes. He was started on bicarbonate infusion due to persistent lactic acidosis (LA), however showed no significant improvement. He was started on IV dexamethasone on 3rd day of hospitalization based on preliminary result of peripheral picture which led to some improvement in LA. Following the confirmation of mantle cell lymphoma (MCL) on bone marrow (BM) biopsy and immunophenotyping, the patient started receiving VR-CAP regimen (bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone) which led to significant improvement in LA and leukocytosis. After discharge, he received further chemotherapy with resolution of the LA and normalization of blood counts. Restaging tests confirmed a complete remission with resolution of the skin rash, resolution of the pathological lymphadenopathy and hepatosplenomegaly on imaging, and absence of lymphoma on a repeat BM biopsy.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>29293400</pmid><doi>10.1080/15384047.2017.1394550</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1538-4047 |
ispartof | Cancer biology & therapy, 2018-02, Vol.19 (2), p.101-104 |
issn | 1538-4047 1555-8576 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5790396 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Acidosis, Lactic - blood Acidosis, Lactic - drug therapy Acidosis, Lactic - etiology Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bedside to Bench Report Biopsy Bone Marrow - pathology Humans Lactic Acid - blood Lymphoma, Mantle-Cell - blood Lymphoma, Mantle-Cell - complications Lymphoma, Mantle-Cell - drug therapy Lymphoma, Mantle-Cell - pathology Male Paraneoplastic Syndromes - blood Paraneoplastic Syndromes - drug therapy Paraneoplastic Syndromes - etiology Treatment Outcome |
title | Type B lactic acidosis, an uncommon paraneoplastic syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T23%3A29%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20B%20lactic%20acidosis,%20an%20uncommon%20paraneoplastic%20syndrome&rft.jtitle=Cancer%20biology%20&%20therapy&rft.au=Wahab,%20Ahsan&rft.date=2018-02-01&rft.volume=19&rft.issue=2&rft.spage=101&rft.epage=104&rft.pages=101-104&rft.issn=1538-4047&rft.eissn=1555-8576&rft_id=info:doi/10.1080/15384047.2017.1394550&rft_dat=%3Cproquest_pubme%3E1984199609%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1984199609&rft_id=info:pmid/29293400&rfr_iscdi=true |